US President Donald Trump has arrived in Beijing for a high-stakes visit to China, accompanied by an unprecedented entourage of family members, business leaders, and global billionaires. This delegation represents a massive concentration of wealth and corporate power, with the combined net worth of those aboard Air Force One estimated to exceed well more than one trillion dollars. The visit marks a critical diplomatic moment as the leaders of the world's two largest superpowers meet to discuss economic relations and trade. Trump aims to leverage this corporate presence to influence Chinese President Xi Jinping toward opening up the Chinese market for American industry.
The delegation includes high-profile figures such as Tesla CEO Elon Musk, who joined the trip despite a judge's order regarding a civil case involving the tech company OpenAI. Also present are leaders from major corporations like Apple, Boeing, Meta, Mastercard, Visa, Goldman Sachs, and Micron, along with NVIDIA CEO Jensen Huang, who was a last-minute addition in Alaska. Trump used social media to confirm Huang's presence and dismiss conflicting reporting regarding the guest list. These industry titans represent sectors ranging from technology and finance to aerospace and agriculture, reflecting the broad scope of the economic mission currently unfolding in China.
This diplomatic mission signals a potential shift in trade relations as Trump publicly asks President Xi, whom he described as a leader of extraordinary distinction, to open up the Chinese economy. The presence of these business leaders suggests that the administration intends to use corporate expertise to negotiate better access for American firms within the Chinese market. Observers will be watching how these interactions impact future trade policies and whether the inclusion of such a powerful delegation yields tangible concessions from Beijing. Furthermore, the legal status of participants like Elon Musk remains a point of interest as he potentially faces consequences for leaving the country during an ongoing trial.